Suppr超能文献

服用降压药物与心血管结局的知晓情况。

Awareness of Being Prescribed Antihypertensive Medications and Cardiovascular Outcomes.

机构信息

Department of Cardiovascular Medicine, The University of Tokyo.

Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health.

出版信息

Circ J. 2024 Sep 25;88(10):1639-1646. doi: 10.1253/circj.CJ-24-0039. Epub 2024 Apr 4.

Abstract

BACKGROUND

Hypertension is a major cause of cardiovascular disease (CVD). In patients with hypertension, unawareness of the disease often results in poor blood pressure control and increases the risk of CVD. However, data in nationwide surveys regarding the proportion of unaware individuals and the implications of such on their clinical outcomes are lacking. We aimed to clarify the association between unawareness of being prescribed antihypertensive medications among individuals taking antihypertensive medications and the subsequent risk of developing CVD.

METHODS AND RESULTS

This retrospective cohort study analyzed data from the JMDC Claims Database, including 313,715 individuals with hypertension treated with antihypertensive medications (median age 56 years). The primary endpoint was a composite of myocardial infarction, angina pectoris, stroke, heart failure, and atrial fibrillation. Overall, 19,607 (6.2%) individuals were unaware of being prescribed antihypertensive medications. During the follow-up period, 33,976 composite CVD endpoints were documented. Despite their youth, minimal comorbidities, and the achievement of better BP control with a reduced number of antihypertensive prescriptions, unawareness of being prescribed antihypertensive medications was associated with a greater risk of developing composite CVD. Hazard ratios of unawareness of being prescribed antihypertensive medications were 1.16 for myocardial infarction, 1.25 for angina pectoris, 1.15 for stroke, 1.36 for heart failure, and 1.28 for atrial fibrillation. The results were similar in several sensitivity analyses, including the analysis after excluding individuals with dementia.

CONCLUSIONS

Among individuals taking antihypertensive medications, assessing the awareness of being prescribed antihypertensive medications may help identify those at high risk for CVD-related events.

摘要

背景

高血压是心血管疾病(CVD)的主要病因。在高血压患者中,对疾病的认识不足往往导致血压控制不佳,增加 CVD 风险。然而,关于全国性调查中未察觉个体的比例及其对临床结局的影响的数据尚缺乏。我们旨在阐明服用降压药物的个体对其服用降压药物的知晓情况与随后发生 CVD 的风险之间的关系。

方法和结果

本回顾性队列研究分析了 JMDC 理赔数据库中的数据,该数据库包括 313715 名接受降压药物治疗的高血压患者(中位年龄 56 岁)。主要终点是心肌梗死、心绞痛、中风、心力衰竭和心房颤动的复合终点。总体而言,有 19607 人(6.2%)对其服用降压药物的情况未察觉。在随访期间,有 33976 人记录到复合 CVD 终点。尽管他们年轻、合并症少,且降压药物的使用种类减少,血压控制更好,但对服用降压药物的知晓情况不足与发生复合 CVD 的风险增加相关。对服用降压药物的知晓情况不足的危害比分别为心肌梗死 1.16,心绞痛 1.25,中风 1.15,心力衰竭 1.36,心房颤动 1.28。在包括排除痴呆症患者的几项敏感性分析中,结果均相似。

结论

在服用降压药物的个体中,评估对服用降压药物的知晓情况可能有助于识别发生 CVD 相关事件风险较高的患者。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验